JTEC

JTEC FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of JTEC (3446.T) as of Oct 19, 2026 is -83.91 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 302.94 % — a change of -127.70% (lower).

FCF Conversion

-83.91 %

YoY

-127.70%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of JTEC is 2026 -83.91 % . FCF Conversion Rate (FCF/EBITDA) of JTEC was 2025 302.94 % . It decreases by -127.70% lower compared to the previous year.

The JTEC FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
249.19 JPY
Jan 1, 2020
-1,154.71 JPY
Jan 1, 2021
100.06 JPY
Jan 1, 2022
-533.23 JPY
Jan 1, 2023
55.59 JPY
Jan 1, 2024
-39.46 JPY
Jan 1, 2025
302.94 JPY
Jan 1, 2026
-83.91 JPY
The JTEC FCF Conversion history
YEARFCF ConversionYoY
-83.91 %-127.70%
302.94 %-867.75%
-39.46 %-170.99%
55.59 %-110.42%
-533.23 %-632.90%
100.06 %-108.67%
-1,154.71 %-563.39%
249.19 %-21.10%
315.84 %+134.97%
134.42 %-153.85%
-249.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JTEC Stock analysis

What does JTEC do? JTEC Corp, listed on the Tokyo Stock Exchange under ticker 3446.T with ISIN JP3386660009, is a Japanese company operating in the Health Care sector. Headquartered in Ibaraki-shi, Japan, the company employs 64 full-time staff. It completed its initial public offering on February 28, 2018. JTEC Corp develops, designs, manufactures, and sells automation systems, focusing on specialized equipment for scientific and medical applications. The company operates through two business segments. The Optical segment specializes in X-ray nano-collecting mirrors used in synchrotron radiation and X-ray free electron laser facilities, designed for advanced analytical applications in both basic research and industrial contexts. The Life Science and Equipment Development segment focuses on automatic cell culture devices and other automation equipment, serving medical, biotechnology, and research sectors. These devices are developed and sold for use in laboratories and research institutions. The company also provides outsourced manufacturing and proprietary products to research institutes and businesses across various industries. JTEC Corp's website is www.j-tec.co.jp, offering further information about its products and services. The company maintains a presence in the health care industry, leveraging automation technology to support scientific research and medical advancements. Its operations reflect a niche focus on precision engineering for specialized applications in high-tech research environments. JTEC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JTEC stock

FCF Conversion Rate (FCF/EBITDA) of JTEC is -83.91 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of JTEC changed from 302.94 % to -83.91 %, representing a -127.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) JTEC since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s JTEC with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — JTEC

All Key Metrics — JTEC